AGP Executive Report

Medical Access Expansion (UK): Tilray Medical says it’s launching Tilray Medical-branded cannabis flower in the UK via Lyphe Clinic and Lyphe Dispensary, aiming for a direct-to-patient channel and a more integrated prescribing/dispensing model. Regulatory Crackdown (Thailand): Thailand’s government warns dentists not to pre-sign controlled cannabis prescription forms (Por.Tor.33) without examining patients, citing multiple legal and ethics breaches. Clinical Research (Pain): New work on sciatica and neuropathic pain highlights the ongoing search for better treatments, with a focus on genetic and integrative analyses. Safety & Compliance (Aviation): Air India de-rosters two pilots after preliminary drug-screening results, following expanded mandatory testing after a Phuket-Delhi incident involving alleged marijuana use. Industry & Markets (Australia): Vitura Health and Cann Group draw investor attention as distribution and pharmacy-channel strategies shape profitability in regulated medicinal cannabis. Policy Watch (US): A major marijuana rescheduling fight faces a key deadline, keeping research and market rules in flux. CBD Payments (UAE): CBD says it’s become the first UAE bank to enable Open Finance payments from other accounts inside its app, expanding customer payment control.

Marijuana rescheduling: A key U.S. federal deadline is set for Monday in the process to move marijuana from Schedule I to Schedule III, with optional post-hearing briefs due and a recommendation expected before any final DEA decision—potentially reshaping research and patient access. Medical access gap: A Rutgers Health study finds most adults over 65 rarely discuss cannabis with clinicians, and only about one in three report being screened—despite rising use among older adults. Hawaii hemp crackdown fight: Hawaiʻi’s Department of Health has moved to restrict hemp-derived THC products sold without medical marijuana cards, and one retailer is suing to stop the crackdown, arguing the state is re-criminalizing federally legal hemp. Clinical trial signal: A report highlights oral CBD helping with post-surgery ocular pain as effectively as opioids, adding to the growing medical case for CBD-based treatment options. Policy pressure on hemp products: Separate coverage notes ongoing legal and political friction around hemp and cannabis rules, including challenges tied to federal implementation and state-level enforcement.

Policy & Youth Safety: A pediatrician and neuroscientist urge Congress to fully close the “intoxicating hemp” loophole after delta-8 THC products marketed like candy keep slipping through weak oversight and age controls. Law Enforcement Tactics: Goa Police are enlisting courier and postal operators to spot parcel-based cannabis/hashish trafficking, after cases where drugs were hidden in everyday items. Medical/Health Research: Hebrew University researchers report engineered plant seeds can produce and store a key cow-milk protein (ß-casein), a step toward more sustainable dairy ingredients. Cannabis & Courts: North Carolina’s top court upheld the ability to search based on the smell of cannabis, while other court items across the week show ongoing cannabis-related prosecutions and sentencing. Public Health Context: A Canada report highlights $24M in cannabis brain-health research, as policymakers weigh how to study and manage medical use responsibly. Community & Compliance: Local meetings and enforcement actions continue to shape how hemp/cannabis-adjacent products and related concerns play out on the ground.

Aviation & Safety: Airbus says an Air India A320neo lost all three hydraulic systems for about four seconds during a Phuket-to-Delhi flight, causing a 300-foot drop; investigators are also looking at a captain’s suspected marijuana test result after the incident. Cannabis Law (US): North Carolina’s Supreme Court upheld a search tied to the odor of cannabis, saying odor is one factor in the “totality of circumstances” for probable cause. Cannabis & Courts (US): California’s Supreme Court ruled that simply initialing a guilty plea form isn’t enough to show a noncitizen understood deportation risk, opening a new path to challenge plea deals. Medical Hemp/Policy (US): Congress is debating a nationwide ban on hemp, with local impacts for Lancaster County businesses and farmers. Research & Health: A CDC report points to a spike in emergency room diagnoses for severe marijuana-related vomiting illness after a new diagnosis code. Global Agriculture & Land: K-State invites producers to Western Kansas field days as drought pressure grows, while a Māori iwi in Porirua buys back 740 hectares of ancestral coastal land—both underscoring how climate and land access shape health and livelihoods.

Hemp Policy Showdown (US): A Lancaster County, Pennsylvania hemp shop owner says Congress’s planned nationwide ban on many hemp-infused products could hit as soon as Nov. 12, and she’s even floating a “cannabis church” idea to keep THC edibles and oils available for pain and mental health relief. Industry Pushback (US): Montana hemp processors are calling the U.S. Senate’s move to delay a hemp ban a “huge win,” arguing the change buys time to craft a more permanent fix after concerns about THC products ending up in kids’ hands. Medical Cannabis Research (US): A new clinical trial report highlights oral CBD as a potential post-surgery ocular pain option, aiming to match opioid effectiveness. Public Health Signal (US): The CDC reports emergency room diagnoses for severe marijuana-related vomiting illness have spiked after a new diagnosis code, adding pressure on clinicians and regulators. Global Justice (Philippines): A Truth Commission opened hearings into Duterte-era drug war killings, with testimony from a mother whose son was shot after suspected marijuana and “shabu” involvement. Regulatory/Enforcement (UK): Portsmouth court updates include a man remanded over sexual assault and another case involving cannabis possession and drug-driving charges, underscoring ongoing enforcement alongside broader policy debates.

Medical Cannabis Research Funding: Canada is putting $24M into a national cannabis-and-brain-health consortium via CIHR, aiming to clarify how use affects mental health and wellbeing across youth, pregnancy, and frequent users. Clinical CBD/Medical Trials: Avicanna reported Q2 2026 results, highlighting growth in proprietary product sales and progress toward a Q3 launch tied to its QUIX™ platform. Regulatory/Access: A Rhode Island federal judge dissolved an order blocking the state’s social equity and adult-use cannabis licensing program after changes to state law mooted the earlier challenge. Public Health & Safety (Kratom): Massachusetts moved to crack down hard on kratom with an emergency order placing products into Schedule I under state law, citing serious health risks and inconsistent potency. Global Drug-War Accountability: The Philippines’ Duterte drug-war truth commission opened hearings with testimony from a mother whose son was killed over alleged marijuana and shabu dealing. CBD Market/Labeling Watch: A consumer-focused piece urges better labeling and lab-report access for delta-8 THC products, warning that sourcing and testing standards can vary.

Aviation & Safety: Air India says it’s now drug-testing all pilots after a captain on the Phuket–Delhi route tested positive for marijuana, following a separate Airbus report that the A320neo briefly lost key flight controls during a 300-foot drop. Criminal Courts: A Canadian cannabis-smuggling trial ended early when a judge discharged the jury, while in the UK a man was jailed for using a teenager to sell multiple drugs in Grimsby. Prison Security: French gendarmes dismantled a drone network accused of delivering drugs to a prison more than 1,800 times in under two months. Public Health & Policy: Ghana’s NACOC cites a new study estimating 82,500 people use hard drugs (excluding cannabis), with Ashanti’s HIV link highlighted. Medical Hemp/Research: A clinical trial update reports oral CBD can reduce post-surgery ocular pain as effectively as opioids, and separate studies point to medical cannabis benefits for endometriosis patients. Local Enforcement: Michigan lawmakers weigh repealing a 24% wholesale marijuana tax as road funding concerns grow.

Medical Cannabis Research: A UK study in women with endometriosis reports medical cannabis-based products brought sustained improvements in pain, sleep, quality of life, and anxiety at 24 months, with fewer opioid prescriptions over time. Regulation & Compliance: Massachusetts Cannabis Control Commission completed a shelf audit of THC potency on flower labels, finding most products within an accurate range but moving to notify and block noncompliant items. Market Expansion: NatureMed opened its third Kentucky medical cannabis dispensary in Murray, aiming to improve local access for patients. Hemp Legal Fight: A Ninth Circuit decision refused to revive a hemp company’s $2.75M destruction lawsuit against Tacoma, limiting the case. Public Safety (Cannabis-Related): California’s Folsom police received a state grant to fund DUI enforcement and education covering alcohol, cannabis, and other drugs. Industry/Business: GŪD Essence announced a Jacksonville opening Aug. 15, expanding its Florida dispensary footprint.

Medical Access Expansion: NatureMed opened its third Kentucky medical cannabis dispensary in Murray, aiming to cut travel time for patients and offering flower, edibles and vaporizers. Hemp Legal Fight (Hawaiʻi): Hawaiʻi’s Department of Health moved to stop sales of hemp-derived “mood-altering” smokes and gummies, with a shop owner suing to block the crackdown. Policy & Taxes: San Luis Obispo County cut its cannabis business tax back to 6% after pressure from operators; in Michigan, a bill would eliminate the 24% wholesale marijuana tax, arguing revenue fell short. Clinical/Health Research: A CDC-linked report points to rising ER visits for cannabis hyperemesis syndrome; separate research links endometriosis with higher type 2 diabetes risk. Market & Industry: A new forecast projects the U.S. opium and cannabis API market growing to $17.9B by 2033, while Australian medicinal cannabis firms highlight ongoing trial pipelines and market access. Public Safety & Use Patterns: Monitoring the Future reports adult cannabis use near record highs and a first uptick in young adult heroin use in about a decade.

Hemp THC fight in court: A Texas federal judge refused to pause new state restrictions that reclassify intoxicating hemp products as Schedule I while the lawsuit continues, keeping THC curbs in place for now. Public safety & cannabis enforcement: Houston County, Texas wrapped a long-running drug-and-gun investigation with 15 arrests and seizures including 834.6g marijuana and 123.4g meth, underscoring multi-agency pressure on trafficking. Impaired-driving gap: Virginia’s upcoming recreational rollout is colliding with a detection problem—experts say there’s no THC “breathalyzer” equivalent, and oral-fluid testing isn’t widely used, leaving marijuana-impaired driving harder to spot. Medical hemp research signal: A UCSF-led study found inhaled cannabis was linked to about 9% fewer premature heartbeats on use days versus abstinence days, adding nuance to cardiovascular risk conversations. Policy & access: Nebraska confirmed independent Mark Cohen’s ballot status for CD3, while broader hemp regulation battles continue across states.

CBD/Medical Safety: The CDC reports a sharp rise in ER visits tied to cannabis hyperemesis syndrome (CHS) after a new CHS diagnosis code took effect in Oct. 2025, with CHS-related visits jumping from 3.35 to 11.26 per 10,000 ED visits and staying elevated through May 2026. Oncology Research: Lab work suggests some cannabinoids (including CBD and CBGV) may make glioblastoma cells less vulnerable to chemotherapy and radiation by shifting cell-death pathways, raising questions about “anticancer” assumptions and the need for clinical follow-up. Clinical/Patient Impact: A study on fibromyalgia patients found topical CBD can reduce localized pain, while another survey reports people with inflammatory bowel disease report better quality of life and fewer opioids after cannabis use. Policy/Access: A federal judge ruled New Jersey’s labor-peace agreement requirement for cannabis licenses is preempted by federal labor law, clearing a faster appeal path. Legal/Enforcement: Nevada County carried out a major sweep of suspected illegal cannabis grows, destroying thousands of plants and seizing processed cannabis, while an NDPS case in India highlights continued legal scrutiny around cannabis plant parts and packaging. Market/Consumer: New Jersey dispensary Noiré highlights rotating menus and delivery expansion as shoppers look for more guided, education-forward buying.

Medicare CBD access: Michigan’s hemp industry is watching a new CMS pilot that lets certain Medicare beneficiaries receive qualifying hemp-derived products (up to $500 annually) through participating health-care organizations—raising fresh questions about how state rules could decide which companies benefit. CBD/THC policy pressure: The federal hemp ban debate keeps heating up, with lawmakers and courts weighing how THC products should be handled as states and companies position for what comes next. Clinical cannabis research: A new report highlights a plant-derived cannabis preparation as safe and effective for children with autism, adding to the growing clinical conversation around cannabinoid-based treatments. Public health & youth vaping: Metro health experts urge parents to talk early about vaping before school starts, warning that nicotine and other inhaled substances can harm lungs and brain development—an issue that often overlaps with broader cannabis use concerns. Legal system ripple effects: A high-profile murder trial in New York will use an anonymous jury, showing how intense publicity can shape court procedures—while other cases continue to involve cannabis in drug-driving and possession allegations. Industry business moves: Aurora Cannabis responded to Curaleaf’s unsolicited takeover bid, underscoring how consolidation and regulation uncertainty are colliding in medical cannabis markets.

PTSD Treatment Update: A German-led multicenter double-blind trial found pharmaceutical THC (dronabinol) was safe and effective for PTSD-related nightmares, with more than a third of patients reporting no nightmares after 10 weeks, though adverse events were more common than placebo. Hemp Policy Fight: Pennsylvania AG Dave Sunday is backing a federal crackdown on hemp-derived “intoxicating products” with THC, arguing it will clarify enforcement, while hemp advocates warn it could shut down legitimate businesses. Legal Ruling on “Hydroponic Weed”: India’s Allahabad High Court said hydroponic cannabis (“hydroponic weed”/ganja) still counts as cannabis under the NDPS Act, granting bail but reinforcing that cultivation method doesn’t change legal status. CBD/THC Market Access: A U.S. report highlights how daily cannabis use has surged and notes rising ER visits tied to cannabis-related vomiting, underscoring ongoing public-health pressure around THC products. Enforcement & Seizures: Dublin Airport authorities seized €950k in herbal cannabis and crystal meth, arresting a woman in connection with the importation.

Hemp Policy Showdown: U.S. Sen. Katie Britt says she’ll keep fighting a “dangerous loophole” that lets hemp-derived THC products reach children, as the Senate vote delays closing the gap by about a month—keeping many THC gummies, vapes, and smokables on shelves longer. Federal Ban Pressure: Multiple reports point to a looming Nov. 12 federal restriction that could effectively shut down many hemp-derived cannabinoid products, with industry groups warning it would devastate farmers and small businesses. Regulatory Pushback in States: Pennsylvania’s AG is urging Congress to let the federal overhaul take effect, arguing it would clarify enforcement for “intoxicating products,” while hemp advocates warn it could still shutter legitimate businesses. Clinical CBD/Canabinoid Pipeline: Artelo Biosciences enrolled its first patient in a Phase 2 glaucoma study of ART27.13, a peripherally selective synthetic cannabinoid receptor agonist aimed at lowering eye pressure with fewer central side effects. Company Updates: MediPharm Labs set Aug. 13 for Q2 2026 financial results, underscoring continued investment in pharmaceutical-grade cannabinoid concentrates. Local Enforcement Politics: Houston is set to vote on a ballot measure to make low-level marijuana possession the lowest enforcement priority and to ban no-knock warrants.

Hemp Regulation Clash: Seven Virginia hemp businesses sued to block a new state THC cap that would remove a CBD/THC exception, arguing it will wipe out inventory and jobs starting Aug. 15. Product Safety: A Frontiers in Pharmacology analysis of 202 CBD products found many missed label potency and showed contamination risks, including heavy metals and pesticide residues—raising concerns about what shoppers actually get. Medical Cannabis Business: Aurora Cannabis reported 2026 AGM voting results, with shareholders backing its board nominees and auditor appointment, underscoring ongoing investor focus on medical cannabis operators. Clinical Caution for Surgery Patients: A 2026 study linked cannabis use disorder with higher postoperative pain and wound-healing complications, urging patients to disclose cannabis use to surgeons and anesthesia teams. Cannabis in Public Health: The CDC reported rising emergency visits tied to cannabis-related vomiting, while separate reporting highlights illegal drug-laced vapes reaching schoolchildren. Legal/Enforcement Headlines: Ireland extradited alleged Kinahan cartel leader Daniel Kinahan from Dubai on drug-smuggling and money-laundering charges, while Dublin Airport saw a major meth-and-cannabis seizure.

Public Health: The CDC says ER visits for cannabis hyperemesis syndrome jumped 16% from last October to May, with the sharp rise tied largely to a new diagnosis code introduced in fall 2025—clinicians can now label the condition more accurately. Policy & Kids: U.S. Sen. Katie Britt and allies pushed to keep the deadline for closing the “hemp loophole” that allows intoxicating hemp-derived THC products (including delta-8) to be sold with weak age checks, arguing minors can’t wait. Hemp Industry Watch: Vermont regulators warn a new federal hemp definition could disrupt the state’s CBD-heavy business models, even for products that are mostly non-intoxicating. Medical Access & Courts: A report highlights how THC-positive newborn tests can trigger child welfare investigations in states where marijuana is illegal, raising concerns that legal substances and accidental exposure can still lead to family separation. Enforcement: Dublin Airport authorities seized about €950,000 in crystal meth and cannabis in a luggage bust, while Hong Kong Customs arrested a passenger after finding ~6 kg of suspected cannabis buds. Legal/Justice: Ireland extradited alleged crime boss Daniel Kinahan from Dubai to face organized-crime charges.